Back

Bio-Techne shareholders approve Merck KGaA acquisition

Verifying
  • Bio-Techne shareholders approved Merck KGaA’s proposed acquisition at a special meeting.
  • Sept. 18, 2026 marked expiration of the Hart-Scott-Rodino waiting period.
  • Bio-Techne expects closing by late 2026 or early 2027, subject to approvals.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.